Dermatitis, Eczematous Completed Phase 2 Trials for Tradipitant (DB12580)

Also known as: Eczema / Eczema NOS / Eczematous rash / Dermatitis eczematoid / Eczematous dermatitis

IndicationStatusPhase
DBCOND0057011 (Dermatitis, Eczematous)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02651714Tradipitant in Treatment-resistant Pruritus Associated With Atopic DermatitisTreatment